SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043971
Filing Date
2021-08-12
Accepted
2021-08-12 16:10:58
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20210630.htm   iXBRL 10-Q 2148757
2 EX-31.1 svra-ex311_10.htm EX-31.1 16904
3 EX-31.2 svra-ex312_6.htm EX-31.2 16783
4 EX-32.1 svra-ex321_9.htm EX-32.1 10784
  Complete submission text file 0001564590-21-043971.txt   8261544

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA svra-20210630.xsd EX-101.SCH 67552
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20210630_cal.xml EX-101.CAL 49549
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20210630_def.xml EX-101.DEF 176368
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20210630_lab.xml EX-101.LAB 436017
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20210630_pre.xml EX-101.PRE 319845
10 EXTRACTED XBRL INSTANCE DOCUMENT svra-10q_20210630_htm.xml XML 1660791
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 211167642
SIC: 2834 Pharmaceutical Preparations